Nilotinib Impurity 34 | CAS 66521-54-8 - Request Quote
Nilotinib Impurity 34
| SZ CAT No: | SZ-N009062 |
| CAS No | 66521-54-8 |
| Mol.F. | C10H12N2O |
| Mol.Wt. | 176.2 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 1072451-66-1 (HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Nilotinib Impurity 34 is chemically 3-(Dimethylamino)-1-(pyridin-2-yl)prop-2-en-1-one. Nilotinib Impurity 34 is supplied with detailed characterization data compliant with regulatory guideline. Nilotinib Impurity 34 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nilotinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 66521-54-8
Purchase 66521-54-8
Order 66521-54-8
Enquire 66521-54-8
price of 66521-54-8
66521-54-8 Supplier
66521-54-8 Manufacturer
66521-54-8 Exporter
buy high quality Nilotinib Impurity 34
Purchase Nilotinib Impurity 34
Nilotinib Impurity 34 suppliers
Nilotinib Impurity 34 manufacturers
Nilotinib Impurity 34 price
Order Nilotinib Impurity 34
Enquire Nilotinib Impurity 34
Nilotinib Impurity 34 cost
Nilotinib Impurity 34 Supplier
Nilotinib Impurity 34 Distributor
Nilotinib Impurity 34 for Method Validation
Nilotinib Reference Standard
Nilotinib Impurity 34 for ANDA Filing
Nilotinib Impurity 34 for Forced Degradation Studies
Nilotinib Impurity 34 Identification Standards
Nilotinib Impurity 34 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


